Supreme Court dismisses Sanofi's plea to quash criminal proceedings in CBI case
SANOFI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.5 pts less than Nifty Microcap 250 and 0.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
The Supreme Court on 7 Sept 2026 dismissed Sanofi's petition seeking quashing of criminal proceedings against it. The matter relates to a CBI complaint about pharmaceutical supplies to BARC Mysore between 2012 to 2015, with allegations of conspiracy with a BARC employee to influence procurement. The Court ruled on maintainability of prosecution even without an individual employee arraigned. No finding of guilt or merits adjudication was made. The criminal trial remains pending. No penalty, conviction, or operational restriction imposed at this stage.
Sanofi's attempt to end the CBI case failed; criminal trial will now proceed. No immediate financial penalty, but prolonged legal uncertainty remains for shareholders.